Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni La Croce

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Urologic Oncology|December 10, 2016
The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemesMarco Moschini, Shahrokh F Shariat, Mohammad Abufaraj, et al.
The Journal of Sexual Medicine|January 30, 2015
Peyronie's disease and autoimmunity—a real-life clinical study and comprehensive reviewEugenio Ventimiglia, Paolo Capogrosso, Michele Colicchia, et al.
World Journal of Urology|September 3, 2014
Awareness and knowledge of human papillomavirus-related diseases are still dramatically insufficient in the era of high-coverage vaccination programsPaolo Capogrosso, Eugenio Ventimiglia, Rayan Matloob, et al.
Prostate International|January 11, 2021
Multiparametric magnetic resonance imaging and clinical variables: Which is the best combination to predict reclassification in active surveillance patients?Marco Roscigno, Armando Stabile, Giovanni Lughezzani, et al.
Urology|December 20, 2015
Preoperative Favorable Characteristics in Bladder Cancer Patients Cannot Substitute the Necessity of Extended Lymphadenectomy During Radical Cystectomy: A Sensitivity Curve AnalysisMarco Moschini, R Jeffrey Karnes, Giorgio Gandaglia, et al.
Clinical Genitourinary Cancer|June 5, 2020
The Use of Multiparametric Magnetic Resonance Imaging for Follow-up of Patients Included in Active Surveillance Protocol. Can PSA Density Discriminate Patients at Different Risk of Reclassification?Marco Roscigno, Armando Stabile, Giovanni Lughezzani, et al.
European Urology|September 18, 2017
Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for Renal Cell Carcinoma Invading the Supradiaphragmatic Inferior Vena Cava and/or Right AtriumAlessandro Nini, Umberto Capitanio, Alessandro Larcher, et al.
Minerva Urology and Nephrology|April 23, 2026
Detrimental effect of delayed or incomplete BCG protocols administration after trans-urethral tumor resection in patients with non-muscle-invasive bladder cancer: a systematic reviewEttore DI Trapani, Arturo Lo Giudice, Elio Mazzone, et al.
Andrology|September 11, 2022
Which patient may benefit the most from penile prosthesis implantation?Giovanni La Croce, Nicolò Schifano, Edoardo Pescatori, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|July 15, 2026
Focal Therapy for Prostate Cancer: A Treatment Option Reserved for the Ideal Candi-date?Daniele Cignoli, João Paulo Barbosa de Oliveira, Andrea Rodriguez-Serrano, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Urologic Oncology|December 10, 2016
The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemesMarco Moschini, Shahrokh F Shariat, Mohammad Abufaraj, et al.
The Journal of Sexual Medicine|January 30, 2015
Peyronie's disease and autoimmunity—a real-life clinical study and comprehensive reviewEugenio Ventimiglia, Paolo Capogrosso, Michele Colicchia, et al.
World Journal of Urology|September 3, 2014
Awareness and knowledge of human papillomavirus-related diseases are still dramatically insufficient in the era of high-coverage vaccination programsPaolo Capogrosso, Eugenio Ventimiglia, Rayan Matloob, et al.
Prostate International|January 11, 2021
Multiparametric magnetic resonance imaging and clinical variables: Which is the best combination to predict reclassification in active surveillance patients?Marco Roscigno, Armando Stabile, Giovanni Lughezzani, et al.
Urology|December 20, 2015
Preoperative Favorable Characteristics in Bladder Cancer Patients Cannot Substitute the Necessity of Extended Lymphadenectomy During Radical Cystectomy: A Sensitivity Curve AnalysisMarco Moschini, R Jeffrey Karnes, Giorgio Gandaglia, et al.
Clinical Genitourinary Cancer|June 5, 2020
The Use of Multiparametric Magnetic Resonance Imaging for Follow-up of Patients Included in Active Surveillance Protocol. Can PSA Density Discriminate Patients at Different Risk of Reclassification?Marco Roscigno, Armando Stabile, Giovanni Lughezzani, et al.
European Urology|September 18, 2017
Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for Renal Cell Carcinoma Invading the Supradiaphragmatic Inferior Vena Cava and/or Right AtriumAlessandro Nini, Umberto Capitanio, Alessandro Larcher, et al.
Minerva Urology and Nephrology|April 23, 2026
Detrimental effect of delayed or incomplete BCG protocols administration after trans-urethral tumor resection in patients with non-muscle-invasive bladder cancer: a systematic reviewEttore DI Trapani, Arturo Lo Giudice, Elio Mazzone, et al.
Andrology|September 11, 2022
Which patient may benefit the most from penile prosthesis implantation?Giovanni La Croce, Nicolò Schifano, Edoardo Pescatori, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|July 15, 2026
Focal Therapy for Prostate Cancer: A Treatment Option Reserved for the Ideal Candi-date?Daniele Cignoli, João Paulo Barbosa de Oliveira, Andrea Rodriguez-Serrano, et al.
Pageof 4